# GCC Oxygen Therapy Equipment Market

> GCC Oxygen Therapy Equipment Market Research Report By Product Type (Continuous Positive Airway Pressure, Nasal Cannulas, Oxygen Concentrators, Liquid Oxygen Systems, Portable Oxygen Cylinders), By Technology (Conventional Oxygen Therapy, Hyperbaric Oxygen Therapy, Ventilation Techniques, Transcutaneous Oxygen Monitoring), By End Use (Home Care, Hospitals, Emergency Services, Long-term Care Facilities) and By Patient Type (Adult, Pediatric, Geriatric) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.31%
- **2024:** $ 102.9 Million
- **2025:** $ 108.36 Million
- **2035:** $ 181.73 Million
- **Key Players:** Philips (NL), ResMed (AU), Invacare (US), Breas Medical (SE), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), Nidek Medical Products (US)

**Report ID:** MRFR/MED/52295-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/gcc-oxygen-therapy-equipment-market-54057

---

## Market Summary

## **GCC Oxygen Therapy Equipment Market Overview**

As per MRFR analysis, the GCC Oxygen Therapy Equipment Market Size was estimated at 562.25 (USD Million) in 2023. The GCC Oxygen Therapy Equipment Market Industry is expected to grow from 573.5 (USD Million) in 2024 to 1,096.88 (USD Million) by 2035. The GCC Oxygen Therapy Equipment Market CAGR (growth rate) is expected to be around 6.072% during the forecast period (2025 - 2035).

### **Key GCC Oxygen Therapy Equipment Market Trends Highlighted**

The GCC Oxygen Therapy Equipment Market is undergoing notable developments owing to the rising healthcare needs in the region. Some of the fundamental drivers for the market include a high rate of respiratory ailments which has increased the demand for effective oxygen therapy devices. These factors are shaping market expansion.

Moreover, the government policies of the GCC countries towards improving healthcare systems and services also support the market extensively. For example, Saudi Arabia’s Vision 2030 alongside other country-level healthcare plans aims to enhance the patient care value chain and subsequently increases the need for oxygen therapy equipment.

There are also explored opportunities in the region which incorporate modern technologies like telemedicine and remote patient monitoring into the practices of oxygen therapy. Such growing demand for advanced solutions that enhance accessibility and treatment results is especially noticeable within the GCC.

Increased demand for homecare treatment options is also an emerging area for market expansion as patients look for easier ways to access treatment. Shifts in the GCC Oxygen Therapy Equipment Market suggest increasing preference for portability and ease of use among patients, as well as self-sufficiency, with the rising focus on geriatrics.

The addition of smart technologies into oxygen therapy devices is in step with the healthcare digitization goals of the region and is beneficial to providers and patients alike. Moreover, the focus on the training and education of the healthcare workforce on the use of oxygen therapy illustrates the intention to maintain optimal standards of healthcare delivery for patients in the GCC.

In general, the changes in the GCC oxygen therapy market, which consider the healthcare systems of various countries, are a result of the synergy between observing and imagining innovative healthcare solutions alongside advanced technologies, and the deep focus approaches toward patients.

## **GCC Oxygen Therapy Equipment Market Drivers**

### **Increase in Respiratory Diseases**

The GCC Oxygen Therapy Equipment Market Industry is significantly driven by the rising prevalence of respiratory diseases, particularly Chronic Obstructive Pulmonary Disease (COPD) and asthma. According to an Arabian Journal of Respiratory Medicine report, there has been a notable increase in the incidence of COPD in the GCC region, with estimates suggesting that nearly 6% of the population suffers from this condition.

Furthermore, the World Health Organization predicts an annual increase in respiratory diseases attributed to environmental factors, such as pollution and lifestyle changes, motivating healthcare providers to adopt oxygen therapy solutions to manage these conditions effectively. Major organizations, such as the Saudi Ministry of Health, are actively promoting initiatives to enhance respiratory care services, thereby expanding the market for oxygen therapy equipment across the GCC.

### **Growing Aging Population**

The GCC Oxygen Therapy Equipment Market Industry is also positively affected by the increase in the aging population within the region. A report by the United Nations projected that the percentage of individuals aged 60 and above in GCC countries would double by 2040. This demographic shift tends to result in higher incidences of diseases necessitating oxygen therapy equipment, contributing significantly to market growth.

Additionally, the GCC government's health initiatives and aging care programs are encouraging investments in advanced therapeutic devices ensuring high-quality respiratory care for the elderly.

### **Technological Advancements**

Technological innovation is a prominent driver within the GCC Oxygen Therapy Equipment Market Industry, leading to the development of more efficient and user-friendly oxygen delivery systems. The introduction of portable oxygen concentrators and advancements in non-invasive ventilation devices have transformed patient care.

As per the Gulf Health Council, there has been a surge in research and development efforts among key players in the Gulf Cooperation Council, resulting in an in crease in patented technologies designed to optimize oxygen therapy delivery. This has not only improved treatment outcomes but has also stimulated the growth of the market as healthcare facilities increasingly adopt these advanced solutions.

## **GCC Oxygen Therapy Equipment Market Segment Insights**

### **Oxygen Therapy Equipment Market Product Type Insights**

The GCC Oxygen Therapy Equipment Market is experiencing a robust transformation, driven by the increasing prevalence of respiratory diseases and a rising aging population that demands effective therapeutic solutions. Among the various categories of oxygen therapy equipment, the Continuous Positive Airway Pressure (CPAP) devices play a significant role in managing sleep apnea and other chronic respiratory conditions. This segment is seeing heightened demand as awareness surrounding sleep disorders grows.

Nasal Cannulas, known for their comfort and convenience, are also widely adopted due to their ease of use and effectiveness in delivering supplemental oxygen. They are particularly valued in home care settings, where patients require continuous oxygen support without disrupting their daily activities.

Oxygen Concentrators are becoming increasingly popular in the GCC region as they provide a reliable source of oxygen for patients while ensuring the safety and convenience of home-based care. This category is a preferred choice, especially in countries with well-established healthcare infrastructures, due to advancements in technology that enhance the efficiency and portability of these devices.

Liquid Oxygen Systems, though less common, serve a niche market, providing concentrated oxygen that is easy to transport and ideal for patients requiring high flow rates. Portable Oxygen Cylinders continue to be a staple in oxygen therapy, offering flexibility for patients who are active and on-the-go, ensuring they have access to oxygen therapy outside of their homes.

The segmentation within the GCC Oxygen Therapy Equipment Market illustrates diverse needs and preferences among patients and healthcare providers. Each type of equipment addresses specific clinical requirements, contributing to the overall growth of the market. The abiding focus on patient-centered care and the emphasis on enhancing the quality of life for individuals with respiratory issues underline the importance of these product types within the broader landscape of oxygen therapy solutions in the GCC.

Additionally, regional initiatives and health policies aimed at improving respiratory health further catalyze growth, ensuring that advancements in oxygen therapy equipment continue meeting emerging demands. This interplay of factors bolsters the significance of the Product Type segment, ultimately shaping the landscape of oxygen therapy within the GCC.

### **Oxygen Therapy Equipment Market Technology Insights**

The Technology segment of the GCC Oxygen Therapy Equipment Market showcases a diversified landscape characterized by several key techniques, each fulfilling specific therapeutic needs across the region. Conventional Oxygen Therapy remains a cornerstone method, widely utilized in hospitals and home care settings due to its simplicity and effectiveness in treating respiratory issues.

Hyperbaric Oxygen Therapy, though less common, offers significant potential for treating conditions like decompression sickness and facilitates wound healing. Ventilation Techniques are essential in critical care and emergency services, providing life support for patients with severe respiratory distress, underscoring the significance of advanced respiratory support in healthcare systems.

Transcutaneous Oxygen Monitoring is increasingly gaining traction for its non-invasive approach, allowing real-time monitoring of oxygen levels in patients, making it crucial for chronic disease management. As infrastructure in GCC countries expands and healthcare facilities modernize, these technologies are expected to experience significant advancements, aligning with government initiatives to enhance healthcare quality and accessibility.

Market growth in this sector is further propelled by the rising prevalence of respiratory diseases, emphasizing the importance of effective oxygen delivery systems across the region.

### **Oxygen Therapy Equipment Market End Use Insights**

The GCC Oxygen Therapy Equipment Market is witnessing a notable trend in the End Use segment, which plays a crucial role in delivering necessary medical support across various settings. Home care has emerged as a vital area, driven by an increasing preference for treatment in familiar environments and advancements in portable oxygen devices.

Hospitals represent another critical component, showcasing a high demand for sophisticated oxygen delivery systems to support acute respiratory conditions. Emergency services also hold significant importance, requiring efficient oxygen therapy solutions to promptly address medical emergencies, ultimately aiming to reduce patient mortality.

Furthermore, long-term care facilities are increasingly focusing on oxygen therapy due to the rising elderly population and patients with chronic conditions, underlining the need for continuous oxygen support. The GCC region is investing in healthcare infrastructure, further promoting the growth of these segments, with a focus on quality life improvement and patient-centered care.

Each segment's importance underscores the evolving landscape of the GCC Oxygen Therapy Equipment Market, where enhanced accessibility and efficiency are driving substantial market growth and segmentation.

### **Oxygen Therapy Equipment Market Patient Type Insights**

The GCC Oxygen Therapy Equipment Market within the Patient Type segment showcases substantial diversity, encompassing Adult, Pediatric, and Geriatric demographics. This segmentation is critical, as the need for oxygen therapy varies significantly across these groups due to differing respiratory health challenges and conditions. Adults often represent the largest patient population requiring oxygen therapy, primarily due to chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma.

Pediatric cases, while smaller in number, are vital as they focus significantly on congenital and acquired respiratory conditions, necessitating specialized equipment designed for younger patients. Geriatric patients, who frequently experience age-related respiratory issues, emphasize the growing importance of portable oxygen therapy solutions that cater to their mobility needs.

The GCC region is currently experiencing a rise in respiratory conditions, driven by increasing pollution levels and lifestyle changes, thus propelling the demand for tailored oxygen therapy solutions across these patient groups. This growing awareness among healthcare providers and patients about the benefits of oxygen therapy further supports the market's expansion, with significant implications for healthcare systems and equipment providers across the GCC region.

## **GCC Oxygen Therapy Equipment Market Key Players and Competitive Insights**

The GCC [Oxygen Therapy Equipment Market](../../../reports/oxygen-therapy-equipment-market-7516) has been experiencing notable growth due to the increasing prevalence of respiratory diseases, the rising geriatric population, and a greater awareness of oxygen therapy benefits among healthcare professionals and patients. The competitive landscape is characterized by various key players actively engaging in strategic initiatives such as product innovation, partnerships, and acquisitions to enhance their market presence in the region.

Additionally, the government's focus on improving healthcare infrastructure and policies that promote access to advanced healthcare solutions are contributing to the market dynamics. The competitive insights reveal a blend of established and emerging companies, each contributing uniquely to the supply of oxygen therapy equipment tailored for the specific needs of the GCC states.

Invacare Corporation has established itself as a prominent player in the GCC Oxygen Therapy Equipment Market, leveraging its extensive experience in the healthcare sector to offer a wide range of products geared towards improving patient care. The company is renowned for its innovative respiratory products, including portable oxygen concentrators and stationary oxygen systems designed to enhance patient mobility and convenience.

Invacare Corporation's strengths lie in its strong distribution network and robust customer support services, which ensure that healthcare providers and patients have access to their products throughout the GCC region. This strategic positioning allows the company to foster strong relationships with local healthcare institutions, enabling it to meet the rising demand for oxygen therapy solutions effectively.

Drive DeVilbiss Healthcare plays a significant role in the GCC Oxygen Therapy Equipment Market, offering a variety of products that cater to the respiratory needs of patients. The company is known for its high-quality oxygen concentrators, nebulizers, and a range of accessories that enhance the usability of oxygen therapy equipment.

Drive DeVilbiss Healthcare’s market presence is bolstered by its consistent focus on research and development, which aids in the launch of advanced technologies that improve patient outcomes. Furthermore, the company has established partnerships and collaborations with local distributors, enhancing its reach within the GCC.

Recent mergers and acquisitions have further strengthened its foothold by integrating complementary products into its portfolio, allowing Drive DeVilbiss Healthcare to provide comprehensive solutions tailored specifically for the region's healthcare system, thereby enhancing its competitive edge.

### **Key Companies in the GCC Oxygen Therapy Equipment Market Include**

- Invacare Corporation
- Drive DeVilbiss Healthcare
- Air Products and Chemicals
- General Electric
- Fisher and Paykel Healthcare
- Nidek
- Getinge
- [Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products/respiratory.html)
- Philips
- Lowell Medical
- Sunglow Medical
- Breas Medical
- OxySure Systems
- SIMPEDIL
- ResMed

## **GCC Oxygen Therapy Equipment Market Industry Developments**

The GCC Oxygen Therapy Equipment Market has seen several significant developments recently. Notably, the ongoing COVID-19 pandemic has intensified the demand for oxygen therapy equipment across the region, leading to increased investments from major players such as Invacare Corporation and Philips.

In June 2023, Air Products and Chemicals announced a strategic partnership with Medtronic to enhance oxygen delivery systems in healthcare facilities within the GCC. Additionally, Fisher and Paykel Healthcare expanded its operations in Saudi Arabia, reflecting the growing need for advanced respiratory care solutions.

In terms of mergers and acquisitions, Drive DeVilbiss Healthcare acquired a regional competitor in March 2023, reinforcing its market position. The market has also witnessed an uptick in startups focusing on oxygen therapy innovations, with several securing funding from local investors.

The combined efforts and expansions by established firms and new entrants showcase the region's commitment to advancing respiratory healthcare technology. These ongoing changes are crucial in addressing both current and future challenges in the healthcare landscape of the Gulf Cooperation Council, ensuring enhanced patient care and improved health outcomes.

## **GCC Oxygen Therapy Equipment Market Segmentation Insights**

### **Oxygen Therapy Equipment Market Product Type Outlook**

- Continuous Positive Airway Pressure
- Nasal Cannulas
- Oxygen Concentrators
- Liquid Oxygen Systems
- Portable Oxygen Cylinders

### **Oxygen Therapy Equipment Market Technology Outlook**

- Conventional Oxygen Therapy
- Hyperbaric Oxygen Therapy
- Ventilation Techniques
- Transcutaneous Oxygen Monitoring

### **Oxygen Therapy Equipment Market End Use Outlook**

- Home Care
- Hospitals
- Emergency Services
- Long-term Care Facilities

### **Oxygen Therapy Equipment Market Patient Type Outlook**

- Adult
- Pediatric
- Geriatric

## Market Drivers

### Rising Awareness of Home Healthcare Solutions

The increasing awareness of home healthcare solutions is significantly influencing the oxygen therapy-equipment market. Patients and caregivers are becoming more informed about the benefits of receiving oxygen therapy at home, which is often more convenient and cost-effective than hospital visits. This trend is particularly relevant in the GCC, where there is a growing emphasis on patient-centered care. Home healthcare services are projected to grow at a CAGR of around 15% in the region, indicating a robust demand for home-based oxygen therapy equipment. As healthcare systems adapt to this shift, the oxygen therapy-equipment market is likely to see a surge in demand for home-use devices, further driving market growth.

### Increasing Prevalence of Respiratory Disorders

The oxygen therapy-equipment market is experiencing growth due to the rising incidence of respiratory disorders in the GCC region. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, leading to a higher demand for oxygen therapy solutions. According to health statistics, the prevalence of COPD in the GCC is estimated to be around 5-10%, which necessitates the use of oxygen therapy equipment for effective management. This trend is likely to drive the market as healthcare providers seek to improve patient outcomes through enhanced oxygen delivery systems. Furthermore, the aging population in the region is contributing to the increase in respiratory ailments, thereby further propelling the demand for oxygen therapy equipment. As a result, the oxygen therapy-equipment market is poised for significant expansion in response to these health challenges.

### Aging Population and Increased Healthcare Needs

The aging population in the GCC is a significant driver of the oxygen therapy-equipment market. As the demographic landscape shifts, the number of elderly individuals requiring medical assistance, including oxygen therapy, is on the rise. It is estimated that by 2030, the proportion of individuals aged 60 and above in the GCC will reach approximately 15%. This demographic change is likely to lead to an increased prevalence of chronic respiratory conditions, thereby boosting the demand for oxygen therapy equipment. Healthcare providers are expected to focus more on tailored solutions for the elderly, which may include portable and user-friendly oxygen devices. Consequently, the oxygen therapy-equipment market is anticipated to grow in response to the evolving healthcare needs of the aging population.

### Government Initiatives and Healthcare Investments

Government initiatives aimed at improving healthcare infrastructure in the GCC are significantly impacting the oxygen therapy-equipment market. Increased funding for healthcare facilities and the establishment of specialized respiratory care units are expected to enhance the availability of oxygen therapy solutions. For instance, the GCC governments have allocated substantial budgets for healthcare development, with some countries investing over $10 billion in healthcare projects. These investments are likely to facilitate the procurement of advanced oxygen therapy equipment, thereby improving patient access to necessary treatments. Additionally, public health campaigns focused on respiratory health are expected to raise awareness and drive demand for oxygen therapy solutions. Consequently, the oxygen therapy-equipment market is likely to benefit from these proactive measures taken by governments in the region.

### Technological Innovations in Oxygen Delivery Systems

Technological advancements in oxygen delivery systems are playing a crucial role in shaping the oxygen therapy-equipment market. Innovations such as portable oxygen concentrators and smart oxygen therapy devices are enhancing the efficiency and convenience of oxygen delivery. The market is witnessing a shift towards more user-friendly and efficient devices, which are expected to capture a larger share of the market. For instance, the introduction of devices that integrate mobile applications for monitoring oxygen levels is likely to appeal to both patients and healthcare providers. This trend indicates a growing preference for technologically advanced solutions that offer improved patient management. As a result, the oxygen therapy-equipment market is anticipated to expand as these innovations become more widely adopted in the GCC region.

## Future Outlook

The [Oxygen Therapy Equipment Market](https://www.marketresearchfuture.com/reports/oxygen-therapy-equipment-market-7516) is projected to grow at a 5.31% CAGR from 2025 to 2035, driven by increasing respiratory diseases, technological advancements, and rising healthcare expenditure.

**New opportunities:**

- Development of portable oxygen concentrators for home use
- Expansion of telehealth services integrating oxygen therapy
- Partnerships with hospitals for integrated oxygen delivery systems

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Type: Oxygen Concentrators (Largest) vs. Oximeters (Fastest-Growing)

In the GCC oxygen therapy-equipment market, the distribution of market share among the segment values reveals a clear leader in oxygen concentrators, which hold the largest share due to their increasing adoption for home healthcare therapies. Oxygen cylinders and liquid oxygen systems follow, offering portable options for patients with acute needs. Oximeters, while currently a smaller segment, are rapidly gaining traction in both hospital and home settings, contributing to a more diversified market landscape.

The growth trends in this segment are primarily driven by rising respiratory diseases and an aging population that demands more accessible oxygen therapy solutions. Additionally, increasing awareness of chronic conditions like COPD and the push for innovative home healthcare equipment has bolstered the market for oxygen concentrators and oximeters. Enhanced technology in oximeters is contributing to their status as the fastest-growing segment, indicating a shift towards more comprehensive respiratory management solutions.

Oxygen Concentrators (Dominant) vs. Oximeters (Emerging)

Oxygen concentrators are recognized as the dominant force in the GCC oxygen therapy-equipment market, characterized by their efficiency in providing a continuous supply of medical-grade oxygen. They are increasingly favored for home care applications and are preferred over traditional oxygen cylinders due to their cost-effectiveness and convenience. On the other hand, oximeters, though emerging, represent a pivotal shift in patient monitoring and management. Their advanced features allow for real-time assessment of oxygen saturation, making them an invaluable tool in both clinical and home settings. The incorporation of digital technologies in oximeters is anticipated to enhance their market position significantly, catering to the growing demand for precise and user-friendly healthcare solutions.

### By Application: Chronic Obstructive Pulmonary Disease (Largest) vs. Sleep Apnea (Fastest-Growing)

In the GCC oxygen therapy-equipment market, Chronic Obstructive Pulmonary Disease (COPD) currently commands the largest share, significantly influencing the overall landscape of oxygen therapy applications. Meanwhile, Sleep Apnea emerges as the fastest-growing segment, indicating shifting healthcare priorities and an increasing awareness of the condition's impact on sleep quality and overall health.

Growth trends are driven by an enhanced focus on respiratory health, fueled by rising pollution levels and lifestyle changes contributing to various respiratory illnesses. Moreover, technological advancements in oxygen therapy equipment enable the creation of more efficient, portable devices that improve patient adherence and treatment outcomes, further bolstering the expansion of these segments in the market.

Respiratory Distress (Dominant) vs. Pulmonary Hypertension (Emerging)

Respiratory Distress is a dominant segment within the GCC oxygen therapy-equipment market, characterized by a high prevalence of conditions that lead to acute breathing difficulties. This segment benefits from a robust demand for immediate therapeutic interventions and an increasing number of hospitalizations related to respiratory issues. On the other hand, Pulmonary Hypertension represents an emerging segment with a growing recognition of its significance in healthcare. Advances in diagnostics and treatment options for Pulmonary Hypertension are leading to its rising visibility and market share. Equipment tailored for both segments is evolving, highlighting both the urgency of care needed for Respiratory Distress and the precision required in managing Pulmonary Hypertension.

### By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the GCC oxygen therapy-equipment market, hospitals represent the largest segment, capturing a significant share of the overall market. This dominance is largely due to the high demand for oxygen therapy in critical care units and emergency departments, which require advanced and reliable oxygen delivery systems. In contrast, home care settings are emerging rapidly, driven by an increasing preference for at-home healthcare solutions and gradual shifts towards outpatient care.

Growth trends indicate that while hospitals will maintain their leading position, home care settings are witnessing the fastest growth. This surge is attributed to factors such as an aging population, rising prevalence of respiratory diseases, and advancements in portable oxygen technologies. The growing inclination towards cost-effective and convenient care options in home environments is further fueling this segment's rapid expansion.

Hospital (Dominant) vs. Home Care Settings (Emerging)

Hospitals serve as the dominant segment in the GCC oxygen therapy-equipment market, benefiting from well-established infrastructure and the need for specialized medical equipment to manage acute cases. They are equipped with advanced oxygen delivery systems designed for intensive care. Conversely, home care settings are emerging as a significant force, providing more personalized care and increasing comfort for patients. This segment leverages innovations in portable oxygen concentrators and mobile technology, making therapies more accessible and user-friendly while catering to a growing patient base seeking at-home options. The expansion of health insurance coverage for home treatments is also enhancing the attractiveness of this segment.

### By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the distribution channel segment of the GCC oxygen therapy-equipment market, Direct Sales holds the largest share due to established relationships between manufacturers and healthcare providers. Medical Supply Distributors play a significant role, providing broad access to various healthcare facilities. In contrast, Online Sales, while smaller in market share, are quickly gaining traction among consumers seeking convenience and competitive pricing. This shift represents the evolving landscape of oxygen therapy equipment distribution.

Recent trends indicate a robust growth trajectory for Online Sales, driven by increasing digital adoption and the rising popularity of e-commerce platforms. Consumers are increasingly prioritizing easy access to products and detailed information available online. Additionally, the demand for home healthcare solutions is pushing traditional players to adopt online strategies, thereby enhancing their market presence while catering to tech-savvy customers.

Direct Sales (Dominant) vs. Medical Supply Distributors (Emerging)

Direct Sales is characterized by strong relationships between manufacturers and healthcare practitioners, facilitating personalized support and direct access to high-quality products. This distribution method is dominant due to its ability to provide tailored solutions to healthcare facilities, ensuring they meet specific patient needs. Meanwhile, Medical Supply Distributors are emerging as key players in the market. They offer a diverse range of products and establish broad distribution networks, allowing them to reach various healthcare settings effectively. The increasing complexity of healthcare demands drives the growth of these distributors as they facilitate access to essential equipment, thus filling the gaps in the market and responding to the changing needs of healthcare providers.

## Competitive Benchmarking

The oxygen therapy-equipment market is currently characterized by a dynamic competitive landscape, driven by increasing demand for respiratory care solutions and advancements in technology. Key players such as Philips (NL), ResMed (AU), and Invacare (US) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Philips (NL) focuses on integrating digital health solutions into its product offerings, while ResMed (AU) emphasizes cloud-connected devices that facilitate remote patient monitoring. Invacare (US) is actively pursuing partnerships to broaden its distribution channels, thereby enhancing accessibility to its products. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological advancement and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the GCC region. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set trends in innovation and customer service, thereby shaping the overall market dynamics.

In October  Philips (NL) announced the launch of a new line of portable oxygen concentrators designed for enhanced mobility and user-friendliness. This strategic move is likely to cater to the growing demand for home healthcare solutions, reflecting a shift towards more personalized patient care. The introduction of these devices may strengthen Philips' competitive edge by appealing to a broader demographic seeking convenience and efficiency in oxygen therapy.

In September  ResMed (AU) expanded its product portfolio by acquiring a startup specializing in artificial intelligence for respiratory care. This acquisition is indicative of ResMed's commitment to integrating advanced technologies into its offerings, potentially revolutionizing patient monitoring and treatment protocols. By harnessing AI, ResMed may enhance its product efficacy and improve patient outcomes, thereby solidifying its position as a leader in the market.

In August  Invacare (US) entered into a strategic partnership with a regional healthcare provider to enhance distribution capabilities across the GCC. This collaboration is expected to improve product availability and customer service, addressing the growing demand for oxygen therapy equipment in the region. Such partnerships may enable Invacare to tap into new customer segments and strengthen its market foothold.

As of November  current trends in the oxygen therapy-equipment market include a pronounced focus on digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of developing unique value propositions that resonate with consumers in an increasingly sophisticated market.

## Recent News & Developments

The GCC Oxygen Therapy Equipment Market has seen several significant developments recently. Notably, the ongoing COVID-19 pandemic has intensified the demand for oxygen therapy equipment across the region, leading to increased investments from major players such as Invacare Corporation and Philips.

In June 2023, Air Products and Chemicals announced a strategic partnership with Medtronic to enhance oxygen delivery systems in healthcare facilities within the GCC. Additionally, Fisher and Paykel Healthcare expanded its operations in Saudi Arabia, reflecting the growing need for advanced respiratory care solutions.

In terms of mergers and acquisitions, Drive DeVilbiss Healthcare acquired a regional competitor in March 2023, reinforcing its market position. The market has also witnessed an uptick in startups focusing on oxygen therapy innovations, with several securing funding from local investors.

The combined efforts and expansions by established firms and new entrants showcase the region's commitment to advancing respiratory healthcare technology. These ongoing changes are crucial in addressing both current and future challenges in the healthcare landscape of the Gulf Cooperation Council, ensuring enhanced patient care and improved health outcomes.

## Report Scope

| MARKET SIZE 2024 | 102.9(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 108.36(USD Million) |
| MARKET SIZE 2035 | 181.73(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.31% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Philips (NL), ResMed (AU), Invacare (US), Breas Medical (SE), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), Nidek Medical Products (US) |
| Segments Covered | Type, Application, End User, Distribution Channel |
| Key Market Opportunities | Integration of advanced telehealth solutions in the oxygen therapy-equipment market enhances patient accessibility and monitoring. |
| Key Market Dynamics | Rising demand for portable oxygen therapy devices driven by increasing respiratory conditions and regulatory support in the GCC. |
| Countries Covered | GCC |

## Frequently Asked Questions

**Q: What was the market valuation of the oxygen therapy equipment market in 2024?**
A: The market valuation was $102.9 Million in 2024.

**Q: What is the projected market valuation for the oxygen therapy equipment market by 2035?**
A: The projected market valuation for 2035 is $181.73 Million.

**Q: What is the expected CAGR for the oxygen therapy equipment market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 5.31%.

**Q: Which segment had the highest valuation in 2024 for oxygen therapy equipment?**
A: In 2024, the segment with the highest valuation was Oxygen Concentrators, valued at $30.87 Million.

**Q: What are the key applications driving the oxygen therapy equipment market?**
A: Key applications include Chronic Obstructive Pulmonary Disease, valued at $30.0 Million in 2024.

**Q: Which distribution channel is projected to perform best in the oxygen therapy equipment market?**
A: Medical Supply Distributors, with a valuation of $41.16 Million in 2024, are projected to perform best.

**Q: Who are the leading players in the oxygen therapy equipment market?**
A: Key players include Philips, ResMed, Invacare, and Breas Medical.

**Q: What was the valuation of the Home Care Settings segment in 2024?**
A: The Home Care Settings segment was valued at $30.0 Million in 2024.

**Q: How much is the Liquid Oxygen Systems segment projected to grow by 2035?**
A: The Liquid Oxygen Systems segment is projected to grow from $20.0 Million in 2024 to $35.0 Million by 2035.

**Q: What is the valuation of the Oximeters segment in 2024?**
A: The Oximeters segment was valued at $27.03 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gcc-oxygen-therapy-equipment-market-54057*